JDS-CR-004

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameJDS-CR-004
Drug Alias NameJDS-CR-004
ClassificationSmall moleculesNatural product/Extract
Mechanisms of ActionInsulin receptor inhibitors
TargetsInsulin receptor
Therapy Area/IndicationsInsulin ResistancePolycystic Ovary Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesJDS Therapeutics LLC
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJDS Therapeutics LLC
Active IndicationsN/A
Inactive IndicationsInsulin ResistancePolycystic Ovary Syndrome

Other Information

ATC CodeN/A
Related LinksN/A